Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]
Lee CH, Hsieh MJ, Chang SH, et al. Int J Nano. 2019;14:7503–7513.
The authors noticed a mistake in the published paper which was overlooked during the revision stages.
On page 7511, in the Acknowledgments section, the sentence “… Chang Gung Memorial Hospital (Contract No. CMRPG3G1291) for financially supporting this research.” should read “… Chang Gung Memorial Hospital (Contract No. CMRPG3G1291 and CMRPG3G1292) for financially supporting this research.”
The authors apologize for this oversight.
Read the original article
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.